The Impact of Prior Authorization on Buprenorphine Dose, Relapse Rates, and Cost for Massachusetts Medicaid Beneficiaries with Opioid Dependence

ConclusionPrior authorization policies strategically targeted by dose level appear to successfully reduce use of higher than recommended buprenorphine doses. Savings from these policies are modest and may be accompanied by brief increases in relapse rates. Lower doses may decrease diversion of buprenorphine. (Source: Health Services Research)

Detoxification treatments for opiate dependent adolescents.

CONCLUSIONS: It is difficult to draw conclusions on the basis of two trials with few participants. Furthermore, the two studies included did not consider the efficacy of methadone that is still the most frequent drug utilised for the treatment of opioid withdrawal. One possible reason for the lack of evidence could be the difficulty in conducting trials with young people due to practical and ethical reasons.
PMID: 24777492 [PubMed – as supplied by publisher] (Source: Cochrane Database of Systematic Reviews)

Detoxification treatments for opiate dependent adolescents.

CONCLUSIONS: It is difficult to draw conclusions on the basis of two trials with few participants. Furthermore, the two studies included did not consider the efficacy of methadone that is still the most frequent drug utilised for the treatment of opioid withdrawal. One possible reason for the lack of evidence could be the difficulty in conducting trials with young people due to practical and ethical reasons.
PMID: 24777492 [PubMed – as supplied by publisher] (Source: Cochrane Database of Systematic Reviews)

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.